Cargando…
G6PD and chloroquine: Selecting the treatment against SARS‐CoV‐2?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205832/ https://www.ncbi.nlm.nih.gov/pubmed/32281268 http://dx.doi.org/10.1111/jcmm.15312 |
_version_ | 1783530314132357120 |
---|---|
author | Kassi, Eva N. Papavassiliou, Kostas A. Papavassiliou, Athanasios G. |
author_facet | Kassi, Eva N. Papavassiliou, Kostas A. Papavassiliou, Athanasios G. |
author_sort | Kassi, Eva N. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7205832 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72058322020-05-11 G6PD and chloroquine: Selecting the treatment against SARS‐CoV‐2? Kassi, Eva N. Papavassiliou, Kostas A. Papavassiliou, Athanasios G. J Cell Mol Med Editorial John Wiley and Sons Inc. 2020-04-16 2020-05 /pmc/articles/PMC7205832/ /pubmed/32281268 http://dx.doi.org/10.1111/jcmm.15312 Text en © 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial Kassi, Eva N. Papavassiliou, Kostas A. Papavassiliou, Athanasios G. G6PD and chloroquine: Selecting the treatment against SARS‐CoV‐2? |
title | G6PD and chloroquine: Selecting the treatment against SARS‐CoV‐2? |
title_full | G6PD and chloroquine: Selecting the treatment against SARS‐CoV‐2? |
title_fullStr | G6PD and chloroquine: Selecting the treatment against SARS‐CoV‐2? |
title_full_unstemmed | G6PD and chloroquine: Selecting the treatment against SARS‐CoV‐2? |
title_short | G6PD and chloroquine: Selecting the treatment against SARS‐CoV‐2? |
title_sort | g6pd and chloroquine: selecting the treatment against sars‐cov‐2? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205832/ https://www.ncbi.nlm.nih.gov/pubmed/32281268 http://dx.doi.org/10.1111/jcmm.15312 |
work_keys_str_mv | AT kassievan g6pdandchloroquineselectingthetreatmentagainstsarscov2 AT papavassilioukostasa g6pdandchloroquineselectingthetreatmentagainstsarscov2 AT papavassiliouathanasiosg g6pdandchloroquineselectingthetreatmentagainstsarscov2 |